Re: Article
|
4
|
Resverlogix Corp.
|
May 30, 2022 12:45PM
|
Re: Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine
|
9
|
Resverlogix Corp.
|
Mar 18, 2022 12:38AM
|
Re: Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
|
5
|
Resverlogix Corp.
|
Apr 20, 2021 03:33PM
|
Re: Apabetalone’s Beneficial Effects on COVID-19 Published in Prestigious Scientific Journal Cell
|
5
|
Resverlogix Corp.
|
Mar 18, 2021 10:03PM
|
Re: Apabetalone’s Beneficial Effects on COVID-19 Published in Prestigious Scientific Journal Cell
|
2
|
Resverlogix Corp.
|
Mar 19, 2021 05:33PM
|
Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model
|
6
|
Resverlogix Corp.
|
Mar 03, 2021 09:48PM
|
Re: Apabetalone for Pulmonary Arterial Hypertension (APPROACH-2).
|
3
|
Resverlogix Corp.
|
Aug 24, 2021 03:00PM
|
Re: Any day now......
|
2
|
Resverlogix Corp.
|
May 28, 2021 11:05PM
|
Re: Another reason
|
8
|
Resverlogix Corp.
|
Jan 10, 2022 04:47PM
|
Re: Annual and Special Mtg & Corporate Update Presentation 12/22/20 - Rough Transcript
|
7
|
Zenith Epigenetics
|
Jan 08, 2021 01:50AM
|
Re: Annual and Special Mtg & Corporate Update Presentation 12/22/20 - Rough Transcript
|
7
|
Zenith Epigenetics
|
Jan 05, 2021 12:34PM
|
Re: Anne McCaffrey passing
|
5
|
Resverlogix Corp.
|
Jun 05, 2021 12:27AM
|
Re: Anne McCaffrey passing
|
6
|
Resverlogix Corp.
|
Jun 05, 2021 03:28PM
|
Re: AGM is in 1 week
|
4
|
Resverlogix Corp.
|
Jun 15, 2021 02:57PM
|
Re: AGM is in 1 week
|
4
|
Resverlogix Corp.
|
Jun 15, 2021 08:06PM
|
Re: AGM attendance
|
4
|
Resverlogix Corp.
|
May 21, 2022 02:29PM
|
Re: AGM & PP
|
2
|
Resverlogix Corp.
|
Nov 23, 2020 01:11PM
|
Re: After yet another nothingburger on the partnering end.
|
2
|
Resverlogix Corp.
|
Feb 05, 2021 02:10AM
|
Re: Address your Shareholders Donald J. McCaffrey
|
4
|
Resverlogix Corp.
|
May 13, 2020 03:10PM
|
Re: Address your Shareholders Donald J. McCaffrey
|
3
|
Resverlogix Corp.
|
May 13, 2020 04:01PM
|